Alamo Isotopes

Alamo Isotopes is a radiopharmaceutical contract development and manufacturing organization (CDMO) based in San Antonio, Texas. The company specializes in the production, radiolabeling, and distribution of medical isotopes and radiopharmaceuticals used in the diagnosis and treatment of various cancers. In January 2024, Alamo Isotopes was acquired by NorthStar Medical Radioisotopes to bolster NorthStar's manufacturing capacity and geographic reach within the United States. The facility is equipped to handle a variety of therapeutic isotopes, supporting the growing demand for targeted radioligand therapies in the oncology sector. As a specialized service provider, Alamo Isotopes offers end-to-end solutions from isotope sourcing to final drug product manufacturing and logistics.